Incident hyperglycemia, parenteral nutrition administration and adverse outcomes in patients with myeloma admitted for initial auto-SCT

Bone Marrow Transplantation

Volumn 48, Issue 8, 2013, Pages 1117-1122

  Sheean, P M ^a   Kilkus, J M ^b   Liu, D ^a   Maciejewski, J ^c   Braunschweig, C A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Auto SCT; Feeding; Hyperglycemia; Myeloma; Nutrition support; Parenteral nutrition

Indexed keywords

INSULIN; MELPHALAN;

ADULT; ADVERSE OUTCOME; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; COHORT ANALYSIS; DRUG INFUSION; ENGRAFTMENT; ERYTHROCYTE; FEBRILE NEUTROPENIA; FEMALE; GLYCEMIC CONTROL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; INFECTION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOSA INFLAMMATION; MYELOMA; PARENTERAL NUTRITION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME; THROMBOCYTE; TRANSFUSION; VOMITING;

COHORT STUDIES; DATA COLLECTION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPERGLYCEMIA; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PARENTERAL NUTRITION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84881370628     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.11     Document Type: Article

References (34)

1. Eshaghian S, Berenson Jr. Multiple myeloma: Improved outcomes with new therapeutic approaches. Curr Opin Support Palliat Care 2012; 6: 330-336
2. Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003; 348: 1875-1883
3. Harousseau JL. Hematopoietic stem cell transplantation in multiple myeloma. J Natl Compr Canc Netw 2009; 7: 961-970
4. Pasquini MC, W Z. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides 2011, available at http://www.cibmtr.org
5. Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G, Muscaritoli M. ESPEN Guidelines on Parenteral Nutrition: Non-surgical oncology. Clin Nutr 2009; 28: 445-454
6. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-1367
7. Sheean PM, Braunschweig C, Rich E. The incidence of hyperglycemia in hematopoietic stem cell transplant recipients receiving total parenteral nutrition: A pilot study. J Am Diet Assoc 2004; 104: 1352-1360
8. Pleva M, Mirtallo JM, Steinberg SM. Hyperglycemic events in non-intensive care unit patients receiving parenteral nutrition. Nutr Clin Pract 2009; 24: 626-634
9. Suryadevara S, Celestin J, DeChicco R, Austhof S, Corrigan M, Speerhas R et al. Type and prevalence of adverse events during the parenteral nutrition cycling process in patients being prepared for discharge. Nutr Clin Pract 2012; 27: 268-273
10. Sheean PM, Freels SA, Helton WS, Braunschweig CA. Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 656-664
11. Ali NA, O'Brien Jr. JM, Blum W, Byrd JC, Klisovic RB, Marcucci G et al. Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality. Cancer 2007; 110: 96-102
12. Fuji S, Kim SW, Mori S, Fukuda T, Kamiya S, Yamasaki S et al. Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation. Transplantation 2007; 84: 814-820
13. Sonabend RY, McKay SV, Okcu MF, Yan J, Haymond MW, Margolin JF. Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia. J Pediatr 2009; 155: 73-78
14. Surveillance Epidemiology and End Results (SEER) Program. Available at http:// seer.cancer.gov/statfacts/html/mulmy.html#survival(accessed December, 2012
15. World Health Organization. Obesity and Overweight. Available at http:// www.who.int/mediacentre/factsheets/fs311/en/(accessed December, 2012
16. Arends J, Bodoky G, Bozzetti F, Fearon K, Muscaritoli M, Selga G et al. ESPEN guidelines on enteral nutrition: Non-surgical oncology. Clin Nutr 2006; 25: 245-259
17. August DA, Huhmann MB. A.S.P.E.N. clinical guidelines: Nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. Jpen 2009; 33: 472-500
18. American Dietetic Association. Oncology evidence-based nutrition practice guideline. In: American Dietetic Association, ed. Chicago (IL), 2007
19. Habschmidt MG, Bacon CA, Gregoire MB, Rasmussen HE. Medical nutrition therapy provided to adult hematopoietic stem cell transplantation patients. Nutr Clin Pract 2012; 27: 655-660
20. Iversen PO, Wisloff F, Gulbrandsen N. Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support. Clin Nutr 2010; 29: 488-491
21. Dupire S, Wemeau M, Debarri H, Pascal L, Hivert B, Willekens C et al. Prognostic value of PINI index in patients with multiple myeloma. Eur J Haematol 2012; 88: 306-313
22. Fuhrman MP, Charney P, Mueller CM. Hepatic proteins and nutrition assessment. J Am Diet Assoc 2004; 104: 1258-1264
23. Bauer J, Capra S, Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 2002; 56: 779-785
24. Detsky AS, Baker JP, O'Rourke K, Johnston N, Whitwell J, Mendelson RA et al. Predicting nutrition-Associated complications for patients undergoing gastrointestinal surgery. JPEN 1987; 11: 440-446
25. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA et al. What is subjective global assessment of nutritional status? JPEN 1987; 11: 8-13
26. Sherman AC, Coleman EA, Griffith K, Simonton S, Hine RJ, Cromer J et al. Use of a supportive care team for screening and preemptive intervention among multiple myeloma patients receiving stem cell transplantation. Support Care Cancer 2003; 11: 568-574
27. American Diabetes Association. Standards of medical care in diabetes-2012.Diabetes care 2012; 35: S11-S63
28. Cetin T, Arpaci F, Dere Y, Turan M, Ozturk B, Komurcu S et al. Total parenteral nutrition delays platelet engraftment in patients who undergo autologous hematopoietic stem cell transplantation. Nutrition 2002; 18: 599-603
29. Orlandi A, Chavakis E, Seeger F, Tjwa M, Zeiher AM, Dimmeler S. Long-Term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice. Basic Res Cardiol 2010; 105: 703-712
30. Weisdorf SA, Lysne J, Wind D, Haake RJ, Sharp HL, Goldman A et al. Positive effect of prophylactic total parenteral nutrition on long-Term outcome of bone marrow transplantation. Transplantation 1987; 43: 833-838
31. Lee C, Longo VD. Fasting vs dietary restriction in cellular protection and cancer treatment: From model organisms to patients. Oncogene 2011; 30: 3305-3316
32. Lee C, Raffaghello L, Brandhorst S, Safdie FM, Bianchi G, Martin-Montalvo A et al. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med 2012; 4: 124-27
33. Safdie FM, Dorff T, Quinn D, Fontana L, Wei M, Lee C et al. Fasting and cancer treatment in humans: A case series report. Aging 2009; 1: 988-1007
34. Grant BL, Bloch AS, Hamilton KK, Thompson CA. American Cancer Society Complete Guide to Nutrition for Cancer Survivors: Eating Well, Staying Well During and After Cancer; 2nd ed., Atlanta, GA, 2010